Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
The New Microbiologica|March 3, 2018
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trialElisa Colella, Dario Cattaneo, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2011
Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjectsDario Cattaneo, Cristina Gervasoni, Paola Meraviglia, et al.
The Pharmacogenomics Journal|April 14, 2021
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairmentStefania Cheli, Sara Baldelli, Annalisa De Silvestri, et al.
Journal of Diabetes and Metabolic Disorders|August 1, 2025
The multifunctional role of bovine colostrum in managing diabetes: clinical insights and potential therapeutic effectsGilda Aiello, Yalçın Mert Yalçıntaş, Diego Campaci, et al.
Cardiovascular Research|July 27, 2022
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effectsCarla Carnovale, Cristiana Perrotta, Sara Baldelli, et al.
Plos One|December 7, 2013
Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse eventsCristina Gervasoni, Paola Meraviglia, Simona Landonio, et al.
Cellular Microbiology|August 27, 2014
Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROSDonatella Amatore, Rossella Sgarbanti, Katia Aquilano, et al.
Clinical Pharmacokinetics|April 5, 2019
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective AnalysisDario Cattaneo, Sara Baldelli, Andrea Giacomelli, et al.
The Journal of Antimicrobial Chemotherapy|December 30, 2020
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patientsMarco Falcone, Francesco Menichetti, Dario Cattaneo, et al.
Frontiers in Immunology|February 22, 2019
GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB InhibitionDolores Limongi, Sara Baldelli, Paola Checconi, et al.
Pageof 11